Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 13.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.00
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 91.43m
  • Volume: 9,340
  • Market Cap: 12.34m
  • RiskGrade: 146
  • Beta: 0.00

Synairgen Overview

Synairgen is in the pharma and biotech sector and is currently trading at 13.50p per share. In the last year Synairgen's share price has ranged from 11.25p to 26.00p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 32.0% n/a
ROCE 24.8%  
Latest F'cast
P/E 7.0 n/a
PEG n/a n/a
Pr/Revenue 2.5 n/a
Pr/Book 1.9  
Latest F'cast
Revenue n/a -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Synairgen Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 n/a (2.27) (2.72)p n/a n/a n/a n/a 0.0%
31-Dec-14 4.29 1.12 1.42p 22.9 n/a n/a n/a 0.0%
31-Dec-15 0.03 (2.56) (2.47)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (3.40) (3.08)p n/a n/a n/a n/a 0.0%
31-Dec-17 5.03 1.63 1.93p 5.6 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Synairgen Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (5.50) (4.70)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (3.90) (3.00)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Synairgen Company Announcements

Holding(s) in Company 22-Oct-2018 10:05 RNS
Part 2 start of Phase II COPD trial 22-Oct-2018 07:00 RNS
Holding(s) in Company 16-Oct-2018 15:01 RNS

Latest Synairgen Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Synairgen Market Data

Currency UK Pounds
Share Price 13.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.00
52 Week Low 11.25
Volume 9,340
Shares Issued 91.43m
Market Cap 12.34m
Beta 0.00
RiskGrade 146

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.42% above the market average46.42% above the market average46.42% above the market average46.42% above the market average46.42% above the market average
78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average
Price Trend
16.94% below the market average16.94% below the market average16.94% below the market average16.94% below the market average16.94% below the market average
32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average
Income Not Available
Growth Not Available

Synairgen Dividends

No dividends found

Trades for 16-Jan-2019

Time Volume / Share Price
08:57 9,340 @ 13.80p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page